glp 1 clinical trials GLP1 agonists: current and future landscape of for patients with metabolic dysfunction GLP-1 Drug Pipeline 2026 |

Emerging Novel Biomarkers in Allergic Rhinitis: A Narrative Review

2020-05-10

Glutathione is queen in the battle for health and longevitya protector we must protect

10.1556/APhyt.49.2014.2.3 77 KanaiT.TakahashiK.InoueH

Development of GLP-1MK-801 To safely harness the weight-lowering properties of NMDA receptor antagonism, we developed a targeting approach based on the hypothesis that conjugation of MK-801 to a GLP-1 analogue through a chemically cleavable disulfide linker would enhance the therapeutic potential of NMDA receptor antagonism in appetite-regulating brain regions enriched for GLP-1 receptors, while mitigating the adverse effects related to the non-restricted actions of MK-801